查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1589229

低温管瓶市场：按容量、材质、无菌、最终用户分类 - 2025-2030 年全球预测

Cryogenic Vials Market by Capacity (Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml), Material (Polyethylene, Polypropylene), Sterility, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年低温管瓶市值为5.2516亿美元，预计到2024年将达到5.5233亿美元，复合年增长率为5.26%，到2030年将达到7.5219亿美元。

低温管瓶在极低温下保存和储存生物样本方面发挥着至关重要的作用，为医疗保健、製药、研究机构和生物技术公司等行业提供支援。这些管瓶对于维持细胞结构的完整性和生物分子的长期储存至关重要，这使得它们对于再生医学、药物开发和基因工程至关重要。由于对生物银行和个人化医疗的需求不断增加，加上冷冻保存技术的进步，该市场正在经历强劲成长。药物研究活动的快速增加和医疗投资的增加进一步提振了市场。改进材料成分以提高安全性和耐用性、整合智慧标籤以增强样品追踪以及开发环保产品以实现永续性目标的机会管瓶。建议包括投资自动化储存解决方案和加强全球分销网络以开拓新兴市场。然而，市场并非没有挑战。有关医疗级材料和废弃物管理通讯协定的严格规定可能会抑製成长。物流，尤其是低温运输维护，仍然是一项复杂且成本高昂的工作。另一个限制是先进低温管瓶的成本相对较高，这可能会限制小型相关人员的使用。市场竞争格局需要企业不断创新和提高成本效率才能维持发展动能。需要创新的领域包括开发整合物联网监控系统的管瓶、提高材料的再生性以及增强低温系统的可扩展性。专注于具有卓越耐热性和易于使用设计的新型材料的研究倡议对于确保提高低温储存能力至关重要。该市场的特点是成长潜力和波动性相结合，策略规划和积极的研究和开发被认为是利用新兴趋势和克服固有市场挑战的关键。

主要市场统计
基准年[2023] 5.2516 亿美元
预测年份 [2024] 5.5233亿美元
预测年份 [2030] 75219万美元
复合年增长率（%） 5.26%

市场动态：揭示快速发展的低温管瓶市场的关键市场洞察

供需的动态交互作用正在改变低温管瓶市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 生物製药公司和受託研究机构的需求不断增加
    • 生物样本库需求快速成长及生技产业成长
    • 改善新兴经济体的健康服务
  • 市场限制因素
    • 低温管瓶洩漏问题
  • 市场机会
    • 协作分发并开始在线上使用
    • 支持产品可追溯性和可靠性的技术的颠覆
  • 市场问题
    • 处置问题

波特的五力：驾驭低温管瓶市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解低温管瓶市场的外部影响

外部宏观环境因素在塑造低温管瓶市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解低温管瓶市场的竞争格局

低温管瓶市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：低温管瓶市场供应商的绩效评估

FPNV定位矩阵是评估低温管瓶市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製低温管瓶市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对低温管瓶市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物製药公司和合约研究机构的需求增加
      • 生物银行需求快速成长及生技产业成长
      • 改善新兴经济体的健康服务
    • 抑制因素
      • 低温管瓶洩漏问题
    • 机会
      • 合作分销并开始在线提供
      • 支持产品可追溯性和真实性的技术的颠覆
    • 任务
      • 处置问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章低温管瓶市场：依容量

  • 介绍
  • 容量1ml以下
  • 容量：1ml至3ml
  • 容量3ml~5ml
  • 容量5ml以上

第七章低温管瓶市场：依材料分类

  • 介绍
  • 聚乙烯
  • 聚丙烯

第八章低温管瓶市场：无菌

  • 介绍
  • 伽玛射线照射
  • 非无菌
  • 无菌的

第九章低温管瓶市场：依最终用户分类

  • 介绍
  • 药品製造商
  • 医院/诊断中心
  • 研究机构

第10章美洲低温管瓶市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太低温管瓶市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的低温管瓶市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abdos Labtech Private Limited
  • Azer Scientific Inc.
  • Biologix Group Ltd.
  • Cole-Parmer Instrument Company, LLC
  • Corning Incorporated
  • Evergreen Sciences, Inc.
  • EZ Bio Research LLC
  • Sigma-Aldrich Corporation
  • Starlab International GmbH
  • StemCell Technologies Inc.
  • Sumitomo Bakelite Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific, Inc.
  • VWR International LLC
  • Ziath Ltd.
Product Code: MRR-4311CE1A33F4

The Cryogenic Vials Market was valued at USD 525.16 million in 2023, expected to reach USD 552.33 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 752.19 million by 2030.

Cryogenic vials play a pivotal role in the storage and preservation of biological samples at ultra-low temperatures, aiding sectors like healthcare, pharmaceuticals, research institutions, and biotechnology firms. These vials are indispensable for maintaining the integrity of cellular structures and preserving biomolecules for prolonged periods, making them crucial for regenerative medicine, drug development, and genetic engineering. The market is witnessing robust growth fueled by heightened demand for biobanking and personalized medicine, coupled with advancements in cryopreservation technology. An upsurge in pharmaceutical research activities and increasing healthcare investments further propel the market. Opportunities abound in developing vials with improved material composition that enhance safety and durability, integration of smart labeling for enhanced sample tracking, and eco-friendly products to meet sustainability goals. Recommendations include investing in automated storage solutions and enhancing global distribution networks to tap into emerging markets. However, the market is not without challenges. Stringent regulations concerning medical-grade materials and waste management protocols can impede growth. Logistics, especially the maintenance of the cold chain, remains a complex and costly endeavor. Another limitation is the relatively high cost associated with advanced cryogenic vials, potentially restricting access for smaller stakeholders. The market's competitive landscape necessitates constant innovation and cost efficiency for companies to sustain momentum. Areas ripe for innovation include the development of vials that integrate IoT-enabled monitoring systems, improving the reusability of materials, and enhancing the scalability of cryogenic systems. Research initiatives focusing on novel materials with superior thermal resistance and user-friendly designs are vital to ensuring enhanced cryogenic storage capabilities. The market is characterized by a blend of growth potential and volatility, where strategic planning and forward-thinking research and development will be key to capitalizing on emerging trends and overcoming intrinsic market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 525.16 million
Estimated Year [2024] USD 552.33 million
Forecast Year [2030] USD 752.19 million
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cryogenic Vials Market

The Cryogenic Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand from bio-pharmaceutical companies and contract research organizations
    • Surge in demand for bio-banking and growth in biotechnological industry
    • Improving healthcare services in the developing economies
  • Market Restraints
    • Problems associated with leakage of Cryogenic vials
  • Market Opportunities
    • Collaboration in distribution and initiated online availability
    • Technology interruptions supporting product traceability and authenticity
  • Market Challenges
    • Disposal Issue

Porter's Five Forces: A Strategic Tool for Navigating the Cryogenic Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cryogenic Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cryogenic Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cryogenic Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cryogenic Vials Market

A detailed market share analysis in the Cryogenic Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cryogenic Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cryogenic Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cryogenic Vials Market

A strategic analysis of the Cryogenic Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cryogenic Vials Market, highlighting leading vendors and their innovative profiles. These include Abdos Labtech Private Limited, Azer Scientific Inc., Biologix Group Ltd., Cole-Parmer Instrument Company, LLC, Corning Incorporated, Evergreen Sciences, Inc., EZ Bio Research LLC, Sigma-Aldrich Corporation, Starlab International GmbH, StemCell Technologies Inc., Sumitomo Bakelite Co. Ltd., Thermo Fisher Scientific Inc., Thomas Scientific, Inc., VWR International LLC, and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Cryogenic Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Capacity, market is studied across Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml, and Capacity 5 ml and Above.
  • Based on Material, market is studied across Polyethylene and Polypropylene.
  • Based on Sterility, market is studied across Gamma Irradiated, Non-Sterile, and Sterile.
  • Based on End-User, market is studied across Drug Manufacturer, Hospital & Diagnostic Center, and Research Organization.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand from bio-pharmaceutical companies and contract research organizations
      • 5.1.1.2. Surge in demand for bio-banking and growth in biotechnological industry
      • 5.1.1.3. Improving healthcare services in the developing economies
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with leakage of Cryogenic vials
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration in distribution and initiated online availability
      • 5.1.3.2. Technology interruptions supporting product traceability and authenticity
    • 5.1.4. Challenges
      • 5.1.4.1. Disposal Issue
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cryogenic Vials Market, by Capacity

  • 6.1. Introduction
  • 6.2. Capacity 1 ml and Below
  • 6.3. Capacity 1ml to 3 ml
  • 6.4. Capacity 3 ml to 5 ml
  • 6.5. Capacity 5 ml and Above

7. Cryogenic Vials Market, by Material

  • 7.1. Introduction
  • 7.2. Polyethylene
  • 7.3. Polypropylene

8. Cryogenic Vials Market, by Sterility

  • 8.1. Introduction
  • 8.2. Gamma Irradiated
  • 8.3. Non-Sterile
  • 8.4. Sterile

9. Cryogenic Vials Market, by End-User

  • 9.1. Introduction
  • 9.2. Drug Manufacturer
  • 9.3. Hospital & Diagnostic Center
  • 9.4. Research Organization

10. Americas Cryogenic Vials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cryogenic Vials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cryogenic Vials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abdos Labtech Private Limited
  • 2. Azer Scientific Inc.
  • 3. Biologix Group Ltd.
  • 4. Cole-Parmer Instrument Company, LLC
  • 5. Corning Incorporated
  • 6. Evergreen Sciences, Inc.
  • 7. EZ Bio Research LLC
  • 8. Sigma-Aldrich Corporation
  • 9. Starlab International GmbH
  • 10. StemCell Technologies Inc.
  • 11. Sumitomo Bakelite Co. Ltd.
  • 12. Thermo Fisher Scientific Inc.
  • 13. Thomas Scientific, Inc.
  • 14. VWR International LLC
  • 15. Ziath Ltd.

LIST OF FIGURES

  • FIGURE 1. CRYOGENIC VIALS MARKET RESEARCH PROCESS
  • FIGURE 2. CRYOGENIC VIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRYOGENIC VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CRYOGENIC VIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2023